Thanks, eb. I actually hope that management of both Humanigen and Baudax kept the Nasdaq Appeals Panel apprised of this merger/business combination, and that Nasdaq is expecting this move, with the aim of both companies re-gaining compliance with Nasdaq listing standards in this way, either jointly or separately. We actually had until the 21st to accomplish this, if Nasdaq was amenable to the ruse of our voluntary delisting.